Allied Market Research
Loading...
Cart
0
New
New Allied Market Research

Tissue Engineering Market by Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, and Others), Application (Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

A03976
Pages: 227
Oct 2020 | 3303 Views
 
Author(s) : Sayali Shinde , Onkar Sumant
Tables: 93
Charts: 64
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Tissue Engineering Market

Request Now !

The global tissue engineering market was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14.2% from 2020 to 2027.

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences toward development of biological substitutes that restore, maintain, or improve tissue function. To do this process, cells and biomolecules are combined with scaffolds. Scaffold is an artificial or natural structure that mimics real organs. 

Tissue-Engineering-Market,-2020-2027

Get more information on this report : Request Sample Pages

 

Increase in prevalence of chronic diseases & trauma emergencies, rise in awareness related to tissue engineering, technological advancements in 3D bio-printing ,and potential pipeline products drive the market growth. Furthermore, growth in number of R&D activities with rise in awareness of tissue engineering in emerging economies are expected to support the market growth. In addition, increase in focus of key players on tissue engineering based therapies are expected to enhance the tissue engineering market growth during the forecast period. However, stringent government regulations and high cost of treatment are estimated to hamper growth of the market.

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. Healthcare industries have been largely impacted by COVID-19 pandemic. After the COVID?19 pandemic, clinical research in tissue engineering are made unavailable and non?COVID?19 clinical trials are significantly reduced. Meanwhile, many of pharmaceutical and biotech companies have shifted their focus on development of drugs and vaccines for treatment of COVID?19. In addition, significant reduction in cell and tissue donation programs negatively impact growth of the tissue engineering market. Thus, delay & disruptions in clinical research and cancelations or delays in tissue replacement & reconstructive surgeries impend the tissue engineering market growth. 

Tissue Engineering Market Segmentation  

The global tissue engineering market is segmented into type, application, and region. On the basis of type, the market is categorized into synthetic scaffold material, biologically derived scaffold material, and others. The synthetic scaffold material segment is further categorized into synthetic polymer and others. The biologically derived scaffold material segment is sub segmented into collagen and others. On the basis of application, the market is segregated into orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Tissue Engineering Market
By Type

Your browser does not support the canvas element.

Biologically Derived Scaffold Material segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment review 

On the basis of type, the market is categorized into synthetic scaffold material, biologically derived scaffold material, and others. The synthetic scaffold materials segment is expected to grow significantly, owing to its efficiency over other naturally derived materials. Synthetic materials are preferred over other materials as they provide a better outcome.  Presently, the biologically derived materials segment is major revenue contributor in the tissue engineering market, owing to its properties such as biocompatibility, non-toxicity, biodegradability, good cell recognition properties, and easy functionalization.

On the basis of application, the market is categorized into orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental, and others. The tissue engineering market for orthopedics & musculoskeletal application is expected to witness significant growth, owing to rise in adoption of tissue engineered products for orthopedics & musculoskeletal applications, rise in commercialization for bone and cartilage repair tissue engineered products, wide availability of products, and rise in incidences of musculoskeletal disorders with increase in awareness of tissue engineered products. It is estimated the cardiovascular segment would show the highest market growth, owing to rise in incidences of cardiovascular diseases and surge in R&D activities to develop tissue engineered products for cardiology. 

Tissue Engineering Market
By Application

Your browser does not support the canvas element.

Cardiovascular is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific tissue engineering market  

Asia-Pacific presents lucrative opportunities for key players operating in the tissue engineering market, owing to its growth in awareness regarding tissue engineered products, rise in demand for advanced healthcare services in emerging economies, developing R&D sector, and rise in presence of key players in the region. Furthermore, developing healthcare infrastructure and increase in focus on regenerative medicine has led to rapid developments in the market. 

The key players profiled in this report include  AbbVie Inc. (Allergen Plc.), B. Braun Melsungen AG, Becton, Dickinson and Company (C. R. BARD, INC.), Integra LifeSciences, Organogenesis Holdings, Sid Martin Biotech (Axogen), Smith & Nephew Plc. (Osiris Therapeutics), TissueTech Inc., Vericel Corporation, and Zimmer Biomet Holdings, Inc.

Tissue Engineering Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 14.2% during 2019-2026.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the tissue engineering market size along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers tissue engineering market analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global tissue engineering market growth.

Key Market Segments

By Product

  • Synthetic Scaffold Material
    • Synthetic Polymer 
    • Others
  • Biologically Derived Scaffold Material
    • Collagen
    • Others
  • Others

By Application

  • Orthopedics and Musculoskeletal
  • Neurology
  • Cardiovascular
  • Skin and Integumentary
  • Dental
  • Others 

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China 
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East and Africa
 

Chapter 1:Introduction

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

Chapter 2:Executive Summary

2.1.Key findings of the study
2.2.CXO perspective

Chapter 3:Market landscape

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in need for tissue engineering in organ transplantation
3.5.1.2.Advancements in medical equipment technologies
3.5.1.3.Increase in prevalence of chronic diseases and trauma emergencies

3.5.2.Restraint

3.5.2.1.High cost associated with tissue engineered products
3.5.2.2.Hurdles associated with tissue engineering

3.5.3.Opportunity

3.5.3.1.Growth opportunities in emerging markets

3.5.4.Impact analysis

3.6.Market information on kidney and liver tissue engineering
3.7.Market overview: product segment

3.7.1.Cell Therapy
3.7.2.Gene Therapy
3.7.3.Small molecules and biologics

3.8.COVID-19 impact analysis on tissue engineering market

Chapter 4:Tissue Engineering MARKET, BY type

4.1.Overview

4.1.1.Market size and forecast

4.2.Synthetic scaffold material

4.2.1.Key market trends growth factors and opportunities
4.2.2.Market size and forecast, by type

4.2.2.1.Synthetic polymer
4.2.2.2.Others

4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country

4.3.Biologically derived scaffold materials

4.3.1.Key market trends growth factors and opportunities
4.3.2.Market size and forecast, by type

4.3.2.1.Collagen
4.3.2.2.Others

4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country

4.4.Others

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

Chapter 5:Tissue Engineering MARKET, BY Application

5.1.Overview

5.1.1.Market size and forecast

5.2.Orthopedics & musculoskeletal

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Neurology

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Cardiovascular

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Skin & integumentary

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Dental

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

5.7.Others

5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country

Chapter 6:Tissue Engineering MARKET, BY Region

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, key growth factors and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. tissue engineering market, by type
6.2.2.1.2.U.S. tissue engineering market, by application

6.2.2.2.Canada

6.2.2.2.1.Canada tissue engineering market, by type
6.2.2.2.2.Canada tissue engineering market, by application

6.2.2.3.Mexico

6.2.2.3.1.Mexico tissue engineering market, by type
6.2.2.3.2.Mexico tissue engineering market, by application

6.2.3.North America market size and forecast, by type
6.2.4.North America market size and forecast, by application

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany tissue engineering market, by type
6.3.2.1.2.Germany tissue engineering market, by application

6.3.2.2.France

6.3.2.2.1.France tissue engineering market, by type
6.3.2.2.2.France tissue engineering market, by application

6.3.2.3.UK

6.3.2.3.1.UK tissue engineering market, by type
6.3.2.3.2.UK tissue engineering market, by application

6.3.2.4.Italy

6.3.2.4.1.Italy tissue engineering market, by type
6.3.2.4.2.Italy tissue engineering market, by application

6.3.2.5.Spain

6.3.2.5.1.Spain tissue engineering market, by type
6.3.2.5.2.Spain tissue engineering market, by application

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe tissue engineering market, by type
6.3.2.6.2.Rest of Europe tissue engineering market, by application

6.3.3.Europe market size and forecast, by type
6.3.4.Europe market size and forecast, by application

6.4.Asia-pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast

6.4.2.1.Japan

6.4.2.1.1.Japan tissue engineering market, by type
6.4.2.1.2.Japan tissue engineering market, by application

6.4.2.2.China

6.4.2.2.1.China tissue engineering market, by type
6.4.2.2.2.China tissue engineering market, by application

6.4.2.3.Australia

6.4.2.3.1.Australia tissue engineering market, by type
6.4.2.3.2.Australia tissue engineering market, by application

6.4.2.4.India

6.4.2.4.1.India tissue engineering market, by type
6.4.2.4.2.India tissue engineering market, by application

6.4.2.5.South Korea

6.4.2.5.1.South Korea tissue engineering market, by type
6.4.2.5.2.South Korea tissue engineering market, by application

6.4.2.6.Rest of Asia-Pacific market size and forecast

6.4.2.6.1.Rest of Asia-Pacific tissue engineering market, by type
6.4.2.6.2.Rest of Asia-Pacific tissue engineering market, by application

6.4.3.Asia-pacific market size and forecast, by type
6.4.4.Asia-pacific market size and forecast, by application

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast

6.5.2.1.Latin America

6.5.2.1.1.Latin America tissue engineering market, by type
6.5.2.1.2.Latin America tissue engineering market, by application

6.5.2.2.Middle East & Africa

6.5.2.2.1.Middle East & Africa tissue engineering market, by type
6.5.2.2.2.Middle East & Africa tissue engineering market, by application

6.5.3.LAMEA market size and forecast, by type
6.5.4.LAMEA market size and forecast, by application

Chapter 7:Company profiles

7.1.ABBVIE INC. (ALLERGEN PLC.)

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.B. BRAUN MELSUNGEN AG

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance

7.3.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments

7.4.INTEGRA LIFESCIENCES

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments

7.5.ORGANOGENESIS HOLDINGS

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.SID MARTIN BIOTECH (AXOGEN)

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments

7.7.SMITH & NEPHEW PLC. (OSIRIS THERAPEUTICS)

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments

7.8.TISSUETECH INC.

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio

7.9.VERICEL CORPORATION

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance.
7.9.6.Key strategic moves and developments

7.10.ZIMMER BIOMET HOLDINGS, INC.

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.BUSINESS PERFORMANCE

LIST OF TABLES

TABLE 01.GLOBAL TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.GLOBAL SYNTHETIC SCAFFOLD MATERIAL MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.SYNTHETIC SCAFFOLD MATERIAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL BIOLOGICALLY DERIVED SCAFFOLD MATERIAL MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 05.BIOLOGICALLY DERIVED SCAFFOLD MATERIALS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.OTHERS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 08.ORTHOPEDICS & MUSCULOSKELETAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.NEUROLOGY TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.CARDIOVASCULAR TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 11.SKIN & INTEGUMENTARY TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 12.DENTAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.OTHERS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.GLOBAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NORTH AMERICA TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 16.U.S. TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 17.U.S. TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 18.CANADA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 19.CANADA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 20.MEXICO TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 21.MEXICO TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 22.NORTH AMERICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.EUROPE TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 25.GERMANY TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 26.GERMANY TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 27.FRANCE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 28.FRANCE TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 29.UK TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 30.UK TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 31.ITALY TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 32.ITALY TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 33.SPAIN TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 34.SPAIN TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 35.REST OF EUROPE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 36.REST OF EUROPE TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 37.EUROPE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 38.EUROPE TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 40.JAPAN TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.JAPAN TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 42.CHINA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 43.CHINA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 44.AUSTRALIA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 45.AUSTRALIA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 46.INDIA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 47.INDIA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 48.SOUTH KOREA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 49.SOUTH KOREA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 52.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 53.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 54.LAMEA TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 55.LATIN AMERICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 56.LATIN AMERICA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 57.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 58.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 59.LAMEA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 60.LAMEA TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.ABBVIE: COMPANY SNAPSHOT
TABLE 62.ABBVIE: OERATING SEGMENT
TABLE 63.ABBVIE: PRODUCT PORTFOLIO
TABLE 64.ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65.B BRAUN: COMPANY SNAPSHOT
TABLE 66.B BRAUN: PRODUCT SEGMENTS
TABLE 67.B BRAUN: PRODUCT PORTFOLIO
TABLE 68.BD: COMPANY SNAPSHOT
TABLE 69.BD: OERATING SEGMENT
TABLE 70.BD: PRODUCT PORTFOLIO
TABLE 71.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 72.INTEGRA: COMPANY SNAPSHOT
TABLE 73.INTEGRA: OPERATING BUSINESS SEGMENTS
TABLE 74.INTEGRA: PRODUCT PORTFOLIO
TABLE 75.ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 76.ORGANOGENESIS: OPERATING SEGMENTS
TABLE 77.ORGANOGENESIS: PRODUCT PORTFOLIO
TABLE 78.AXOGEN: COMPANY SNAPSHOT
TABLE 79.AXOGEN: OPERATING SEGMENTS
TABLE 80.AXOGEN: PRODUCT PORTFOLIO
TABLE 81.AXOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 82.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 83.SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 84.SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 85.TISSUETECH: COMPANY SNAPSHOT
TABLE 86.TISSUETECH: OPERATING BUSINESS SEGMENTS
TABLE 87.HOLOGIC: PRODUCT PORTFOLIO
TABLE 88.VERICEL: COMPANY SNAPSHOT
TABLE 89.VERICEL: OPERATING SEGMENTS
TABLE 90.VERICEL: PRODUCT PORTFOLIO
TABLE 91.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 92.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 93.ZIMMER BIOMET: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.TISSUE ENGINEERING MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.LOW THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS:
FIGURE 13.SYNTHETIC POLYMER MARKET, 2019 - 2027 ($MILLION)
FIGURE 14.OTHERS MARKET, 2019 - 2027 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS SYNTHETIC SCAFFOLD MATERIAL TISSUE ENGINEERING MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 16.COLLAGEN MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 17.OTHERS MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS BIOLOGICALLY DERIVED SCAFFOLD MATERIALS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OTHERS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS ORTHOPEDICS & MUSCULOSKELETAL TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS NEUROLOGY TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS CARDIOVASCULAR TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS SKIN & INTEGUMENTARY TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS DENTAL TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OTHERS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 26.U.S. TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 27.CANADA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 28.MEXICO TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 29.GERMANY TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 30.FRANCE TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 31.UK TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 32.ITALY TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 33.SPAIN TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 34.REST OF EUROPE TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 35.JAPAN TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 36.CHINA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 37.AUSTRALIA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 38.INDIA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 39.SOUTH KOREA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 40.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 41.LATIN AMERICA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 42.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 43.ABBVIE: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.ABBVIE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 45.B BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.B BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.B BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.BD: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.BD: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.INTEGRA: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.INTEGRA: REVENUE SHARE, BY SEGMENT, 2019(%)
FIGURE 53.INTEGRA: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 54.ORGANOGENESIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.ORGANOGENESIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 56.AXOGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 57.SMITH & NEPHEW: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.SMITH & NEPHEW: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 59.SMITH & NEPHEW: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 60.VERICEL: NET SALES, 2017–2019 ($MILLION)
FIGURE 61.VERICEL: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 62.ZIMMER BIOMET: NET SALES, 2017–2019 ($MILLION)
FIGURE 63.ZIMMER BIOMET: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 64.ZIMMER BIOMET: REVENUE SHARE, BY REGION, 2019(%)

 
 

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences toward development of biological substitutes that restore or improve tissue function. Tissue engineering involves use of a tissue scaffold for formation of new viable tissues for medical purposes. Tissue engineering is applicable for various indications such as orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, and dental. 

Increase in patient awareness toward tissue engineering, increase in prevalence of trauma injuries, technological advancements in the field of 3D tissue engineering, and higher number of R&D activities to develop ideal tissue engineered products drive growth of the tissue engineering market. However, stringent regulations and higher cost hinder the growth of the market. 

North America is expected to remain dominant during the forecast period, owing to higher adoption of these products, ease of accessibility, and presence of major key players along with R&D centers fuel the market growth. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to increase in patient awareness toward tissue engineering with rise in penetration of key players in the emerging countries in Asia-Pacific. 
 

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Tissue Engineering market is $2,374 million in 2019.

A. The forcast period for Tissue Engineering market is 2020 to 2027

A. The market value of Tissue Engineering market in 2020 is $2,688 million.

A. The base year is 2019 in Tissue Engineering market

A. Top companies such as AbbVie Inc. (Allergen Plc.), Smith & Nephew Plc. (Osiris Therapeutics), Integra LifeSciences and others. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Biologically derived Scaffold Material segment most influencing segment in market, owing to its properties such as biocompatibility, non toxicicty, biodegradability, good cell recognition properties, easy functionalization and others are majorly drives the market growth of this segment

A. The major factors that drive the global Tissue Engineering market include rise in awareness related to tissue engineering, technological advancement in 3D bio-printing and potential pipeline products will drive the market growth.

A. Asia-Pacific has the highest growth rate 16.3% in the market which is growing due to growth in awareness about tissue engineered products, rise in demand of advanced healthcare services in the emerging economies, developing R&D sector, and rise in presence of key players in this region influence the market growth.

A. Tissue engineering is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function. To do this process, cells and biomolecules are combined with scaffolds. Scaffold is an artificial or natural structure that mimics real organs

A. Tissue Engineering product use for different application areas such as orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental and others

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Tissue Engineering Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts